NASDAQ:RCEL
AVITA Medical, Inc. Stock News
$8.27
+0.350 (+4.42%)
At Close: May 17, 2024
AVITA Medical to Announce Third Quarter 2022 Financial Results
04:01pm, Thursday, 20'th Oct 2022
VALENCIA, Calif. and MELBOURNE, Australia, Oct. 20, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization
AVITA Medical, Inc. (RCEL) CEO Dr. Mike Perry on Q2 2022 Results - Earnings Call Transcript
09:03pm, Thursday, 11'th Aug 2022
AVITA Medical, Inc. (NASDAQ:RCEL ) Q2 2022 Results Conference Call August 11, 2022 5:00 PM ET Company Participants Caroline Corner - Managing Director, Investor Relations Dr. Mike Perry - Chief Execut
AVITA Medical to Announce Second Quarter 2022 Financial Results
04:01pm, Monday, 25'th Jul 2022
VALENCIA, Calif., and MELBOURNE, Australia, July 25, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a tec
AVITA Medical, Inc. (RCEL) CEO Mike Perry on Q1 2022 Results - Earnings Call Transcript
10:19pm, Thursday, 12'th May 2022
AVITA Medical, Inc. (NASDAQ:RCEL ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Caroline Corner - Managing Director, Investor Relations Mike Perry - Chief Executive Of
AVITA Medical Reports First Quarter 2022 Financial Results
08:14pm, Thursday, 12'th May 2022 GlobeNewswire Inc.
VALENCIA, Calif. and MELBOURNE, Australia, May 12, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company that is developing and c
AVITA Medical to Announce First Quarter 2022 Financial Results
08:01pm, Thursday, 28'th Apr 2022 GlobeNewswire Inc.
VALENCIA, Calif. and MELBOURNE, Australia, April 28, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a t
AVITA Medical to Announce First Quarter 2022 Financial Results
04:01pm, Thursday, 28'th Apr 2022
VALENCIA, Calif. and MELBOURNE, Australia, April 28, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a tec
RECELL® System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation Annual Scientific Symposium
08:01pm, Wednesday, 23'rd Mar 2022 GlobeNewswire Inc.
VALENCIA, Calif. and MELBOURNE, Australia, March 23, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a t
AVITA Medical Announces Modification of BARDA Contract to Advance Development of RECELL® System in Soft Tissue Reconstruction
08:01pm, Monday, 21'st Mar 2022 GlobeNewswire Inc.
Funds will support completion of the ongoing pivotal clinical trial Funds will support completion of the ongoing pivotal clinical trial
The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO
12:46pm, Thursday, 03'rd Mar 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
NuCana Discontinues Biliary Tract Cancer Study Following Futility Analysis
NuCana plc (NASDAQ: NCNA) s
AVITA Medical Inks Supply Pact With Premier For RECELL System
09:44am, Thursday, 03'rd Mar 2022
AVITA Medical Inc (NASDAQ: RCEL) has been awarded a group purchasing agreement with Premier Inc (NASDAQ: PINC) The new agreement allows Premier members, at their discretion, to take advantage of
Avita Medical, Inc. Signs Agreement with Premier, Inc. to Supply the RECELL® System to Hospitals and Health Systems Across the U.S.
09:01pm, Wednesday, 02'nd Mar 2022 GlobeNewswire Inc.
Agreement ensures timely access to the RECELL System for the approximately 4,440 U.S. hospitals and health systems in Premier’s network Agreement ensures timely access to the RECELL System for the a
AVITA Medical Reports Quarter Ending December 31, 2021, and Transition Period July 1, 2021, to December 31, 2021, Financial Results
09:01pm, Monday, 28'th Feb 2022 GlobeNewswire Inc.
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 28, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH) (the “Company”), a regenerative medicine company that is developing and c
AVITA Medical Inc. (RCEL) CEO Mike Perry on Q4 2021 Results - Earnings Call Transcript
08:55pm, Monday, 28'th Feb 2022
AVITA Medical Inc. (RCEL) CEO Mike Perry on Q4 2021 Results - Earnings Call Transcript
The RECELL® System Receives PMDA Approval in Japan and AVITA Medical will Commercialize in Partnership with COSMOTEC, an M3 Group Company
09:29pm, Wednesday, 23'rd Feb 2022 GlobeNewswire Inc.
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a te
